Bergan Kdv Wealth Management, LLC Biogen Inc. Transaction History

Bergan Kdv Wealth Management, LLC

$999 Million
Q2 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$252.44 - $306.72 $504 - $613	-2 Reduced 16.67%	10 $2,000
Q3 2022 Oct 24, 2022	SELL	$194.69 - $268.46 $9,734 - $13,422	-50 Reduced 80.65%	12 $3,000
Q2 2022 Jul 13, 2022	SELL	$187.54 - $223.02 $187 - $223	-1 Reduced 1.59%	62 $13,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $581 - $732	-3 Reduced 4.55%	63 $13,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $13,583 - $17,714	-48 Reduced 42.11%	66 $19,000
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $971 - $1,138	-4 Reduced 3.39%	114 $32,000
Q4 2020 Feb 04, 2021	BUY	$236.26 - $355.63 $236 - $355	1 Added 0.85%	118 $29,000
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $47,129 - $54,416	-178 Reduced 60.34%	117 $33,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $313,495 - $415,170	-1,212 Reduced 80.42%	295 $79,000
Q1 2020 Apr 24, 2020	SELL	$268.85 - $341.04 $65,330 - $82,872	-243 Reduced 13.89%	1,507 $477,000
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $14,744 - $20,372	-67 Reduced 3.69%	1,750 $519,000
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $133,290 - $149,498	-613 Reduced 25.23%	1,817 $423,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $41,884 - $46,168	-191 Reduced 7.29%	2,430 $568,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $55,261 - $86,434	-255 Reduced 8.87%	2,621 $620,000
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $6,684 - $8,466	-24 Reduced 0.83%	2,876 $865,000
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $61,930 - $80,988	-211 Reduced 6.78%	2,900 $1.03 Million
Q2 2018 Jul 23, 2018	BUY	$257.52 - $306.91 $78,543 - $93,607	305 Added 10.87%	3,111 $903,000
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $15,347 - $21,706	59 Added 2.15%	2,806 $768,000
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $42,761 - $47,896	139 Added 5.33%	2,747 $875,000
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $733,239 - $859,831	2,608	2,608 $817,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.

Account